Mustang Bio Announces Closing of $8 Million Public Offering
Mustang Bio Announces Pricing of $8 Million Public Offering
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
Stay informed and receive company updates straight to your inbox.